Circulating immune checkpoints predict heart failure outcomes

Circulating immune checkpoints predict heart failure outcomes

Abstract Aims There are limited data examining the role of immune checkpoint (IC) ligands in the pathophysiology of heart failure (HF). Therefore, we explore this in three HF animal models and in three different human cohorts (healthy, stable, and worsening HF). Methods and results Transcriptomic an...

Mô tả đầy đủ

Chi tiết về thư mục
Những tác giả chính:	Elles M. Screever, Laura I.E. Yousif, Javid J. Moslehi, Joe‐Elie Salem, Adriaan A. Voors, Herman H.W. Silljé, Rudolf A. deBoer, Wouter C. Meijers
Định dạng:	Bài viết
Ngôn ngữ:	English
Được phát hành:	Wiley 2023-08-01
Loạt:	ESC Heart Failure
Những chủ đề:	Immune checkpoints PD‐L1 PD‐L2 Galectin‐9 Heart failure
Truy cập trực tuyến:	https://doi.org/10.1002/ehf2.14304

Những quyển sách tương tự

Expression patterns of immune checkpoints in acute myeloid leukemia
Bằng: Cunte Chen, et al.
Được phát hành: (2020-04-01)

Neurologic toxicity associated with immune checkpoint inhibitors: a pharmacovigilance study
Bằng: Douglas B. Johnson, et al.
Được phát hành: (2019-05-01)

Checkpoint Inhibition in Myeloma: Opportunities and Challenges
Bằng: Federica Costa, et al.
Được phát hành: (2018-09-01)

The role of immune checkpoints in cardiovascular disease
Bằng: Laura I. Yousif, et al.
Được phát hành: (2022-10-01)

Enhancing cancer care with improved checkpoint inhibitors
Bằng: Vickram A S, et al.
Được phát hành: (2024-10-01)

Checkmate with checkpoint inhibitors: New paradigm in immunotherapy
Bằng: Ruby Dhar, et al.
Được phát hành: (2023-04-01)

Characterization of PD-1/PD-L1 Immune Checkpoint Expression in Osteosarcoma
Bằng: Kazuhiko Hashimoto, et al.
Được phát hành: (2020-07-01)

Immune Checkpoint in Glioblastoma: Promising and Challenging
Bằng: Jing Huang, et al.
Được phát hành: (2017-05-01)

Phytochemicals in Cancer Immune Checkpoint Inhibitor Therapy
Bằng: Juwon Lee, et al.
Được phát hành: (2021-07-01)

Overview of the Cardiotoxicity Induced by PD-1/PD-L1 Immune Checkpoint Inhibitor in Critical Care
Bằng: Ruiting Li, et al.
Được phát hành: (2021-06-01)

On Demand Biosensors for Early Diagnosis of Cancer and Immune Checkpoints Blockade Therapy Monitoring from Liquid Biopsy
Bằng: Sai Mummareddy, et al.
Được phát hành: (2021-12-01)

PD-1/PD-L1 immune checkpoint inhibitors in glioblastoma: clinical studies, challenges and potential
Bằng: Tianrui Yang, et al.
Được phát hành: (2021-02-01)

PD-L1 expression on malignant cells is no prerequisite for checkpoint therapy
Bằng: Jan Willem Kleinovink, et al.
Được phát hành: (2017-04-01)

Current Progress and Future Perspectives of Immune Checkpoint in Cancer and Infectious Diseases
Bằng: Xin Cai, et al.
Được phát hành: (2021-11-01)

Epigenetic modifications of the immune-checkpoint genes CTLA4 and PDCD1 in non-small cell lung cancer results in increased expression
Bằng: Sebastian Marwitz, et al.
Được phát hành: (2017-05-01)

Immune Checkpoint Inhibitors in Cancer Therapy
Bằng: Yavar Shiravand, et al.
Được phát hành: (2022-04-01)

Immune Checkpoints and Innovative Therapies in Glioblastoma
Bằng: Massimo Romani, et al.
Được phát hành: (2018-10-01)

Research Progress on Cardiotoxicity of PD-1/PD-L1 Immune Checkpoint Inhibitors
Bằng: YU Lin, et al.
Được phát hành: (2021-08-01)

The Role of Immune Checkpoint Inhibitors in Cancer Therapy
Bằng: Ahmed M. Basudan
Được phát hành: (2022-12-01)

The role of immune checkpoint inhibitors in prostate cancer
Bằng: Gabriel Surdacki, et al.
Được phát hành: (2019-03-01)

Editorial: The Roles of Checkpoint Inhibitors in Inflammatory Diseases
Bằng: Andreas von Knethen, et al.
Được phát hành: (2021-10-01)

Activity and Safety of Immune Checkpoint Inhibitors in Neuroendocrine Neoplasms: A Systematic Review and Meta-Analysis
Bằng: Alberto Bongiovanni, et al.
Được phát hành: (2021-05-01)

Immune checkpoint blockade therapy for bladder cancer treatment
Bằng: Jayoung Kim
Được phát hành: (2016-06-01)

Predictive Biomarkers of Immune Checkpoint Inhibitors-Related Toxicities
Bằng: Ya Xu, et al.
Được phát hành: (2020-10-01)

Structural Characterization of a Macrocyclic Peptide Modulator of the PD-1/PD-L1 Immune Checkpoint Axis
Bằng: Edyta Zyla, et al.
Được phát hành: (2021-08-01)

The Neonatal Innate Immune Response to Sepsis: Checkpoint Proteins as Novel Mediators of This Response and as Possible Therapeutic/Diagnostic Levers
Bằng: Emily Hensler, et al.
Được phát hành: (2022-07-01)

Key questions about the checkpoint blockade-are microRNAs an answer?
Bằng: Mihnea Dragomir, et al.
Được phát hành: (2018-06-01)

Vascular Targeting to Increase the Efficiency of Immune Checkpoint Blockade in Cancer
Bằng: Maria Georganaki, et al.
Được phát hành: (2018-12-01)

Enhancement of anti-tumor efficacy of immune checkpoint blockade by alpha-TEA
Bằng: William L. Redmond, et al.
Được phát hành: (2023-02-01)

The epigenetic immunomodulator, HBI-8000, enhances the response and reverses resistance to checkpoint inhibitors
Bằng: Reid P. Bissonnette, et al.
Được phát hành: (2021-08-01)

Advances in immune checkpoint inhibitors for hepatocellular carcinoma
Bằng: Ji Won Han, et al.
Được phát hành: (2021-09-01)

Immune Checkpoint Inhibitors: Ctla-4 and Pd-1/Pd-l1 in Immunotherapy
Bằng: Kübra KAHVECİ, et al.
Được phát hành: (2019-12-01)

Radiation, Immune Checkpoint Blockade and the Abscopal Effect: A Critical Review on Timing, Dose and Fractionation
Bằng: Zachary S. Buchwald, et al.
Được phát hành: (2018-12-01)

Safety and efficacy of PD-1/PD-L1 immune checkpoint inhibitors in patients with pre-treated advanced stage malignant mesothelioma: a systematic review and meta-analysis
Bằng: Amjad Zafar, et al.
Được phát hành: (2024-11-01)

Immune checkpoint expression and relationships to anti‐PD‐L1 immune checkpoint blockade cancer immunotherapy efficacy in aged versus young mice
Bằng: Myrna G. Garcia, et al.
Được phát hành: (2022-03-01)

The impact of antibiotic use on clinical features and survival outcomes of cancer patients treated with immune checkpoint inhibitors
Bằng: Jiaxin Zhou, et al.
Được phát hành: (2022-07-01)

Tumor immunotherapies by immune checkpoint inhibitors (ICIs); the pros and cons
Bằng: Adel Naimi, et al.
Được phát hành: (2022-04-01)

Editorial: Biomarkers of Immune-Checkpoint-Inhibitor Immunotherapies in Hepatocellular Carcinomas
Bằng: Zhanjun Guo, et al.
Được phát hành: (2022-03-01)

Profiling targetable immune checkpoints in osteosarcoma
Bằng: Troy A McEachron, et al.
Được phát hành: (2018-12-01)

The Use of Phytochemicals to Improve the Efficacy of Immune Checkpoint Inhibitors: Opportunities and Challenges
Bằng: Deniz Can Guven, et al.
Được phát hành: (2022-10-01)